CY1331A - Ergot peptide derivatives - Google Patents

Ergot peptide derivatives

Info

Publication number
CY1331A
CY1331A CY1331A CY133180A CY1331A CY 1331 A CY1331 A CY 1331A CY 1331 A CY1331 A CY 1331A CY 133180 A CY133180 A CY 133180A CY 1331 A CY1331 A CY 1331A
Authority
CY
Cyprus
Prior art keywords
peptide derivatives
ergot peptide
ergot
derivatives
peptide
Prior art date
Application number
CY1331A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH547779A external-priority patent/CH643560A5/de
Priority claimed from CH547679A external-priority patent/CH642082A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1331A publication Critical patent/CY1331A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
CY1331A 1979-06-12 1980-06-09 Ergot peptide derivatives CY1331A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH547979 1979-06-12
CH547879 1979-06-12
CH547779A CH643560A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use
CH547679A CH642082A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
CY1331A true CY1331A (en) 1986-06-27

Family

ID=27428898

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1331A CY1331A (en) 1979-06-12 1980-06-09 Ergot peptide derivatives

Country Status (24)

Country Link
US (1) US4547500A (xx)
AR (1) AR231142A1 (xx)
AU (1) AU545645B2 (xx)
CA (1) CA1169856A (xx)
CY (1) CY1331A (xx)
DE (1) DE3020895A1 (xx)
DK (1) DK250580A (xx)
ES (3) ES8105331A1 (xx)
FI (1) FI70222C (xx)
FR (1) FR2458552A1 (xx)
GB (2) GB2053908B (xx)
HK (1) HK40286A (xx)
HU (1) HU184299B (xx)
IE (1) IE49610B1 (xx)
IL (1) IL60287A (xx)
IT (1) IT1146938B (xx)
KE (1) KE3622A (xx)
MA (1) MA18872A1 (xx)
NL (1) NL8003318A (xx)
NO (1) NO154635C (xx)
NZ (1) NZ193992A (xx)
PH (1) PH19334A (xx)
PT (1) PT71374B (xx)
SE (2) SE445645B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571927B2 (en) * 1979-06-12 1988-04-28 Sandoz Ltd. A 2-methyl ergot peptide alkaloid
CH656533A5 (de) * 1982-12-10 1986-07-15 Sandoz Ag Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
CA2838991A1 (en) 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
CH588485A5 (en) * 1973-10-12 1977-06-15 Sandoz Ag (17)-Ergolene derivs. prepn. - from lysergic acid (6)-(N)-oxide derivs.
CH587858A5 (xx) * 1973-11-28 1977-05-13 Sandoz Ag
CH610330A5 (en) * 1974-09-27 1979-04-12 Sandoz Ag Process for the preparation of novel ergopeptins
CH601321A5 (xx) * 1975-01-06 1978-07-14 Sandoz Ag
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives

Also Published As

Publication number Publication date
IE49610B1 (en) 1985-10-30
IL60287A0 (en) 1980-09-16
SE457260B (sv) 1988-12-12
IE801206L (en) 1980-12-12
IT8048924A0 (it) 1980-06-10
FI70222B (fi) 1986-02-28
AR231142A1 (es) 1984-09-28
CA1169856A (en) 1984-06-26
PT71374A (en) 1980-07-01
HU184299B (en) 1984-07-30
NZ193992A (en) 1982-12-21
DK250580A (da) 1980-12-13
MA18872A1 (fr) 1980-12-31
NO154635B (no) 1986-08-11
FI70222C (fi) 1986-09-15
SE8500490D0 (sv) 1985-02-04
SE445645B (sv) 1986-07-07
SE8500490L (sv) 1985-02-04
KE3622A (en) 1986-05-16
SE8004306L (sv) 1980-12-13
NL8003318A (nl) 1980-12-16
IL60287A (en) 1986-03-31
FR2458552A1 (fr) 1981-01-02
AU5923380A (en) 1980-12-18
GB2053908B (en) 1983-11-30
ES498872A0 (es) 1982-06-01
ES8205194A1 (es) 1982-06-01
ES492332A0 (es) 1981-05-16
ES498871A0 (es) 1982-06-01
GB2121030A (en) 1983-12-14
PT71374B (en) 1981-06-25
ES8205195A1 (es) 1982-06-01
ES8105331A1 (es) 1981-05-16
GB2053908A (en) 1981-02-11
FR2458552B1 (xx) 1983-08-19
AU545645B2 (en) 1985-07-25
HK40286A (en) 1986-06-06
IT1146938B (it) 1986-11-19
US4547500A (en) 1985-10-15
NO801724L (no) 1980-12-15
NO154635C (no) 1986-11-19
PH19334A (en) 1986-03-21
DE3020895A1 (de) 1980-12-18
GB2121030B (en) 1984-05-23
FI801810A (fi) 1980-12-13

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
MY8500273A (en) Pyrrlidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2121030B (en) Ergot peptide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
MY8400201A (en) Isopropylamino-pyrimidine derivatives
IL60090A0 (en) Tetrahydrophthalamide derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2065110B (en) Decaprenylamine derivatives
GB2065109B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
GB2042521B (en) Ergoline derivatives
IL60000A0 (en) Tripeptide derivatives
GB2060606B (en) Propionamidoxime derivatives
GB2122186B (en) Oxapenem derivatives
GB2055374B (en) -amino-3 nor-tropane derivatives